MMP1 and non-small cell lung carcinoma: To further investigate the mechanism of erlotinib resistance in NSCLC, the transcription factors targeting MMP1 were explored by FunRich analysis, HOXA9, PBX1, JUND, JUNB, and JUN were identified to be the top five transcription factors which targeting MMP1 (Fig. 5a).